Everyone snores occasionally and it’s generally not something to worry about. But if
Scheriproct Ointment
the items you wish
to order
by our qualified
prescriber
to your door step
Please use the options provided to make your final selection.

Brand | Medicine Strength | Size | Price |
---|---|---|---|
- | - | 30g x 1 Tube | 19.00 |
- | - | 30g x 2 Tubes | 31.00 |
It looks like you missed filling in questions from the last consultation.Click Here to submit your response.
About Scheriproct Ointment
Scheriproct Ointment contains the active ingredients Cinchocaine Hydrochloride and Prednisolone Hexanoate. It is used to treat haemorrhoids (piles). Scheriproct is classified as a Prescription-only-medicine (POM). Scheriproct Ointment comes in a 30g tube, which includes an attachable plastic applicator and a detailed patient information leaflet (PIL).
Cinchocaine belongs to a group of medicines called local anaesthetics. These medicines work by blocking the pain messages along the nerve fibers. This prevents the pain signals from reaching the brain, creating a numbing sensation in the area where the ointment has been absorbed. When treating piles, using a local anaesthetic such as Cinchocaine will numb the affected area, reducing the pain and itching associated with haemorrhoids.
The other active ingredient, Prednisolone belongs to a category of medicines known as; Corticosteroids. These medicines work to relieve pain and inflammation. Inflammation is caused by an immune response that causes blood vessels to dilate (widen), resulting in the affected area becoming red, painful, itchy and swollen. Prednisolone works from within the cell. It actively reduces the substances produced by the body that trigger the inflammation. When Prednisolone is used to treat Haemorrhoids, it will effectively reduce the painful inflammation and swelling caused by this condition.
Scheriproct Ointment is designed for short-term relief from the symptoms of haemorrhoids and anal itching. This is usually between five and seven days.
Scheriproct is a combination medication that contains two active medications: prednisolone hexanoate, which is a glucocorticoid steroid and reduces inflammation, and cinchocaine hydrochloride, an anesthetic that works locally to relieve pain. These scheriproct ointment uses include being utilised to relieve inflammation (that is, swelling, redness, itching, and pain) caused by hemorrhoids (also known as piles) and itching in your anus.
Scheriproct ointment contains the active ingredients Cinchocaine and Prednisolone, which together relieve the uncomfortable symptoms caused by hemorrhoids. Cinchocaine acts as a local anesthetic numbs the affected area, and consequently relieves pain and irritation. Prednisolone is an effective steroid and reduces inflammation of hemorrhoids, preventing swelling and itching.
Scheriproct is a treatment for hemorrhoids. It contains two active ingredients, which work by relieving pain and reducing inflammation in the affected area. The treatment is available in our pharmacy as an ointment. In most cases, the ointment is applied twice a day. However, in the first days of treatment, your doctor may recommend increasing the amount to control symptoms as quickly as possible.
It is very important that you wash your hands after using the treatment. You should also wash and dry the affected area before applying the treatment. You should apply the ointment for external or internal use on the affected area for five to seven days (three to four times on the first day, if necessary). After the symptoms disappear, you should apply the ointment once a day for a few days.
Before applying the scheriproct ointment dosage, which will preferably be done after defecation, it should be cleaned while taking care of the anal region. The rapidity with which the improvement usually occurs should not induce to conclude the treatment prematurely. To avoid relapse, after the discomfort has disappeared, the treatment must be continued for at least one week, although with intervals of longer administration (one application of ointment per day). However, care should be taken that the duration of treatment does not exceed 4 weeks.
If the doctor does not prescribe otherwise, in general, the ointment will be applied 3 times a day, with the exception of the first day of treatment, in which to get a quick elimination of discomfort, you can use the ointment up to 4 times.
A pea-sized amount of ointment is sufficient for each application, which will spread with the finger in the anal region and ring, overcoming with the tip of the finger the resistance of the sphincter.
For intrarectal application, the cannula included in the package will be used, screwing it onto the
ointment. Before very inflamed and painful processes, it may be advisable to use your finger as well for intrarectal application. Prolapsed nodules should be covered with a thick layer of ointment and, if possible, very carefully try to replace it with your finger. If the nodules external are very inflamed, it is recommended to take a sitz bath before applying the preparation
Like all medicines, This haemorrhoid treatment cream can cause side effects, although not everyone will suffer from them.
The following Scheriproct ointment side effects may occur during treatment. These affect the skin in the anal region:
Common (may affect up to 1 in 10 people):
- skin burns
Uncommon (may affect up to 1 in 100 people):
- Skin irritation (for example, redness, dryness)
- allergic reactions (eg skin rash)
- When using Scheriproct Ointment for a longer period (more than 4 weeks), there is a risk of that local skin reactions may develop, such as: thinning of the skin (atrophy), uneven areas of skin that look like streaks enlarged blood vessels that are visible on the surface of the skin (telangiectasias).
Precautions.
Pregnancy and lactation: Experimental clinical trials in animals with glucocorticoids have shown reproductive toxicity. A series of epidemiological studies suggest that there may possibly be an increased risk of cleft lip and palate in newborn infants of women who were treated with systemic glucocorticoids during the first trimester of pregnancy. There is insufficient information regarding the use of topical glucocorticoids during pregnancy; however, a lower risk can be expected, since the systemic availability of topically applied glucocorticoids is very low. As a general rule, topical preparations containing corticosteroids should not be applied during the first trimester of pregnancy. The clinical indication for Scheriproct treatment should be carefully considered and the risk-benefit ratio in pregnant and lactating women should be carefully assessed. In particular, prolonged treatment should be avoided. Excretion with milk of effective amounts of active glucocorticoids is unlikely.
You can buy Scheriproct Ointment online through one of the UK’s leading online pharmacies, Pharmacy Planet. It's easy and convenient. You will need to fill out a short assessment and the item will be delivered directly to your door. If you want to buy Scheriproct Ointment 30g online, use Pharmacy Planet, a UK pharmacy you can trust.

clinical consultation
Answer a few questions on your health and your fitness goals.

assessment
Our clinicians will review your clinical questionnaire to make sure treatment is right for you.

aboard!
Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical weight loss journey.
Start your journey with us
Need Help?

Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.
To get in touch, contact our Customer Service team on 0800 978 8956 or email headoffice@pharmacyplanet.com.

Authored By
HARMINDER ‘HARMY’ KAUR
BSc(hons) Pharmacy
GPhC Number: 2061107

Reviewed By
GURDEV SEHMI
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925